Review Article

You have full text access to this OnlineOpen article

An updated catalog of prostate cancer predictive tools†

  1. Shahrokh F. Shariat MD1,‡,*,
  2. Pierre I. Karakiewicz MD2,
  3. Claus G. Roehrborn MD1,
  4. Michael W. Kattan PhD3

Article first published online: 29 SEP 2008

DOI: 10.1002/cncr.23908

Issue

Cancer

Cancer

Volume 113, Issue 11, pages 3075–3099, 1 December 2008

Additional Information

How to Cite

Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G. and Kattan, M. W. (2008), An updated catalog of prostate cancer predictive tools. Cancer, 113: 3075–3099. doi: 10.1002/cncr.23908

Author Information

  1. 1

    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas

  2. 2

    Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada

  3. 3

    Department of Quantitative Health Sciences, The Cleveland Clinic, Cleveland, Ohio

  1. ‡

    Fax: (214) 648-8786

*Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110

  1. †

    See editorial on pages 3062–6, this issue.

Publication History

  1. Issue published online: 17 NOV 2008
  2. Article first published online: 29 SEP 2008
  3. Manuscript Revised: 4 JUN 2008
  4. Manuscript Accepted: 3 JUN 2008
  5. Manuscript Received: 11 NOV 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (447K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Idir Ouzaid, David R. Yates, Vincent Hupertan, Pierre Mozer, Emmanuel Chartier-Kastler, Alain Haertig, Marc-Olivier Bitker, Morgan Rouprêt, A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy, The Prostate, 2012, 72, 10
    Direct Link:
  2. 2
    Takumi Shiraishi, Robert H Getzenberg, Prakash Kulkarni, Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer, Asian Journal of Andrology, 2012, 14, 3, 400

    CrossRef

  3. 3
    Heidi A. van Vugt, Monique J. Roobol, Martijn Busstra, Paul Kil, Eric H. Oomens, Igle J. de Jong, Chris H. Bangma, Ewout W. Steyerberg, Ida Korfage, Compliance with biopsy recommendations of a prostate cancer risk calculator, BJU International, 2012, 109, 10
    Direct Link:
  4. 4
    Andreas Josefsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Lars Karlberg, Pär Stattin, Anders Bergh, Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance, Scandinavian Journal of Urology and Nephrology, 2012, 1

    CrossRef

  5. 5
    Eugene K. Cha, Shahrokh F. Shariat, Matthias Kormaksson, Giacomo Novara, Thomas F. Chromecki, Douglas S. Scherr, Yair Lotan, Jay D. Raman, Wassim Kassouf, Richard Zigeuner, Mesut Remzi, Karim Bensalah, Alon Weizer, Eiji Kikuchi, Christian Bolenz, Marco Roscigno, Theresa M. Koppie, Casey K. Ng, Hans-Martin Fritsche, Kazumasa Matsumoto, Thomas J. Walton, Behfar Ehdaie, Stefan Tritschler, Harun Fajkovic, Juan I. Martínez-Salamanca, Armin Pycha, Cord Langner, Vincenzo Ficarra, Jean-Jacques Patard, Francesco Montorsi, Christopher G. Wood, Pierre I. Karakiewicz, Vitaly Margulis, Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma, European Urology, 2012, 61, 4, 818

    CrossRef

  6. 6
    Nadeem Riaz, Asim Afaq, Oguz Akin, Xin Pei, Marisa A. Kollmeier, Brett Cox, Hedvig Hricak, Michael J. Zelefsky, Pretreatment Endorectal Coil Magnetic Resonance Imaging Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated With Combination Brachytherapy and External-Beam Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, 2012,

    CrossRef

  7. 7
    Herbert Augustin, Marco Auprich, Sebastian Mannweiler, Oliver Pachernegg, Badereddin Mohamad Al-Ali, Karl Pummer, Prostate cancers detected by saturation repeat biopsy impairs the Partin tables’ accuracy to predict final pathological stage, BJU International, 2012, 109, 12
    Direct Link:
  8. 8
    Lars Budäus, Hendrik Isbarn, Pierre Tennstedt, Georg Salomon, Thorsten Schlomm, Thomas Steuber, Alexander Haese, Felix Chun, Margit Fisch, Uwe Michl, Hans Heinzer, Hartwig Huland, Markus Graefen, Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients, BJU International, 2012, 109, 12
    Direct Link:
  9. 9
    Maxwell V. Meng, Peter R. Carroll, Campbell-Walsh Urology, 2012,

    CrossRef

  10. 10
    Sheng Fei Oon, Stephen R. Pennington, John M. Fitzpatrick, R. William G. Watson, Biomarker research in prostate cancer—towards utility, not futility, Nature Reviews Urology, 2011, 8, 3, 131

    CrossRef

  11. 11
    Anna Dahlman, Elton Rexhepaj, Donal J Brennan, William M Gallagher, Alexander Gaber, Anna Lindgren, Karin Jirström, Anders Bjartell, Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis, Modern Pathology, 2011, 24, 5, 708

    CrossRef

  12. 12
    Abraham S. Alexander, Aminudin Mydin, Stuart O. Jones, Jennifer Christie, Jan T.W. Lim, Pauline T. Truong, Charles M. Ludgate, Extreme-Risk Prostate Adenocarcinoma Presenting With Prostate-Specific Antigen (PSA) >40 ng/ml: Prognostic Significance of the Preradiation PSA Nadir, International Journal of Radiation Oncology*Biology*Physics, 2011, 81, 5, e713

    CrossRef

  13. 13
    Adam C. Reese, Natalia Sadetsky, Peter R. Carroll, Matthew R. Cooperberg, Inaccuracies in assignment of clinical stage for localized prostate cancer, Cancer, 2011, 117, 2
    Direct Link:
  14. 14
    Hajime Uno, Tianxi Cai, Michael J. Pencina, Ralph B. D'Agostino, L. J. Wei, On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data, Statistics in Medicine, 2011, 30, 10
    Direct Link:
  15. You have free access to this content15
    Andrew J. Vickers, Prediction models in cancer care, CA: A Cancer Journal for Clinicians, 2011, 61, 5
    Direct Link:
  16. 16
    Jack Cuzick, Gregory P Swanson, Gabrielle Fisher, Arthur R Brothman, Daniel M Berney, Julia E Reid, David Mesher, VO Speights, Elzbieta Stankiewicz, Christopher S Foster, Henrik Møller, Peter Scardino, Jorja D Warren, Jimmy Park, Adib Younus, Darl D Flake, Susanne Wagner, Alexander Gutin, Jerry S Lanchbury, Steven Stone, Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study, The Lancet Oncology, 2011, 12, 3, 245

    CrossRef

  17. 17
    Chan Kyo Kim, Satoru Takahashi, Prostate cancer: Predicting tumor aggressiveness using DWI-guided biopsy, Nature Reviews Urology, 2011,

    CrossRef

  18. 18
    Andrea Salonia, Andrea Gallina, Alberto Briganti, Giuseppe Zanni, Nazareno Suardi, Umberto Capitanio, Renzo Colombo, Roberto Bertini, Massimo Freschi, Giorgio Guazzoni, Patrizio Rigatti, Francesco Montorsi, Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy, BJU International, 2011, 107, 8
    Direct Link:
  19. 19
    Shahrokh F. Shariat, Thomas F. Chromecki, Julia Hoefer, Christopher E. Barbieri, Douglas S. Scherr, Pierre I. Karakiewicz, Claus G. Roehrborn, Francesco Montorsi, Zoran Culig, Ilaria T. Cavarretta, Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner, The Journal of Urology, 2011, 186, 5, 2107

    CrossRef

  20. 20
    Schuyler Halverson, Matthew Schipper, Kevin Blas, Vivien Lee, Aaron Sabolch, Karin Olson, Howard M. Sandler, Felix Y. Feng, Daniel A. Hamstra, The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse, Radiotherapy and Oncology, 2011, 101, 3, 513

    CrossRef

  21. 21
    Matthew R. Cooperberg, Joan F. Hilton, Peter R. Carroll, The CAPRA-S score, Cancer, 2011, 117, 22
    Direct Link:
  22. 22
    Shahrokh F. Shariat, Axel Semjonow, Hans Lilja, Caroline Savage, Andrew J. Vickers, Anders Bjartell, Tumor markers in prostate cancer I: Blood-based markers, Acta Oncologica, 2011, 50, S1, 61

    CrossRef

  23. 23
    S. A. Tomlins, S. M. J. Aubin, J. Siddiqui, R. J. Lonigro, L. Sefton-Miller, S. Miick, S. Williamsen, P. Hodge, J. Meinke, A. Blase, Y. Penabella, J. R. Day, R. Varambally, B. Han, D. Wood, L. Wang, M. G. Sanda, M. A. Rubin, D. R. Rhodes, B. Hollenbeck, K. Sakamoto, J. L. Silberstein, Y. Fradet, J. B. Amberson, S. Meyers, N. Palanisamy, H. Rittenhouse, J. T. Wei, J. Groskopf, A. M. Chinnaiyan, Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA, Science Translational Medicine, 2011, 3, 94, 94ra72

    CrossRef

  24. 24
    A Gupta, M J Roobol, C J Savage, M Peltola, K Pettersson, P T Scardino, A J Vickers, F H Schröder, H Lilja, A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands, British Journal of Cancer, 2010, 103, 5, 708

    CrossRef

  25. 25
    Shahrokh F. Shariat, Derya Tilki, Bladder cancer: Nomogram aids clinical decision making after radical cystectomy, Nature Reviews Urology, 2010, 7, 4, 182

    CrossRef

  26. 26
    Herbert Augustin, Maxine Sun, Hendrik Isbarn, Karl Pummer, Pierre Karakiewicz, Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage, Urologic Oncology: Seminars and Original Investigations, 2010,

    CrossRef

  27. You have free access to this content27
    Norio Nonomura, Hitoshi Takayama, Atsunari Kawashima, Masatoshi Mukai, Akira Nagahara, Yasutomo Nakai, Masashi Nakayama, Akira Tsujimura, Kazuo Nishimura, Katsuyuki Aozasa, Akihiko Okuyama, Decreased infiltration of macrophage scavenger receptor-positive cells in initial negative biopsy specimens is correlated with positive repeat biopsies of the prostate, Cancer Science, 2010, 101, 6
    Direct Link:
  28. 28
    Richard Viney, Editorial Comment to Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases, International Journal of Urology, 2010, 17, 11
    Direct Link:
  29. 29
    Herbert Augustin, Hendrik Isbarn, Marco Auprich, Daniela Bonstingl, Baderedin Mohamad Al-Ali, Sebastian Mannweiler, Karl Pummer, Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer, European Journal of Cancer, 2010, 46, 12, 2235

    CrossRef

  30. 30
    Juan Morote, Jokin del Amo, Angel Borque, Elisabet Ars, Carlos Hernández, Felipe Herranz, Antonio Arruza, Roberto Llarena, Jacques Planas, María J. Viso, Joan Palou, Carles X. Raventós, Diego Tejedor, Marta Artieda, Laureano Simón, Antonio Martínez, Luis A. Rioja, Improved Prediction of Biochemical Recurrence After Radical Prostatectomy by Genetic Polymorphisms, The Journal of Urology, 2010, 184, 2, 506

    CrossRef

  31. 31
    Adam C. Reese, Matthew R. Cooperberg, Peter R. Carroll, Minimal Impact of Clinical Stage on Prostate Cancer Prognosis Among Contemporary Patients With Clinically Localized Disease, The Journal of Urology, 2010, 184, 1, 114

    CrossRef

  32. 32
    Daniel M Moreira, Joseph C Presti Jr, William J Aronson, Martha K Terris, Christopher J Kane, Christopher L Amling, Leon L Sun, Judd W Moul, Stephen J Freedland, Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases, International Journal of Urology, 2010, 17, 11
    Direct Link:
  33. 33
    Andrew Vickers, Prediction Models in Urology: Are They Any Good, and How Would We Know Anyway?, European Urology, 2010, 57, 4, 571

    CrossRef

  34. 34
    Sung Yoon Park, Chan Kyo Kim, Byung Kwan Park, Hyun Moo Lee, Kyung Soo Lee, Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results, European Radiology, 2010, 21, 5, 1111

    CrossRef

  35. 35
    Giovanni Lughezzani, Alberto Briganti, Pierre I. Karakiewicz, Michael W. Kattan, Francesco Montorsi, Shahrokh F. Shariat, Andrew J. Vickers, Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature, European Urology, 2010, 58, 5, 687

    CrossRef

  36. 36
    A. Horwich, C. Parker, C. Bangma, V. Kataja, Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2010, 21, Supplement 5, v129

    CrossRef

  37. 37
    A. Ouzzane, P. Koenig, C. Ballereau, L. Zini, T. Ghoneim, F. Maladry, J.-C. Fantoni, J. Biserte, X. Leroy, A. Villers, Résultats carcinologiques après prostatectomie totale pour cancer : validation française de la classification de D’Amico, Progrès en Urologie, 2010, 20, 13, 1206

    CrossRef

  38. 38
    Florian R. Schroeck, Michael W. Kattan, Judd W. Moul, William J. Aronson, Joseph C. Presti Jr, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Leon Sun, Stephen J. Freedland, Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy, BJU International, 2010, 105, 12
    Direct Link:
  39. 39
    Heidi A van Vugt, Chris H Bangma, Monique J Roobol, Should prostate-specific antigen screening be offered to asymptomatic men?, Expert Review of Anticancer Therapy, 2010, 10, 7, 1043

    CrossRef

  40. 40
    Mark R. Newton, Sharon Phillips, Sam S. Chang, Peter E. Clark, Michael S. Cookson, Rodney Davis, Jay H. Fowke, S. Duke Herrell, Roxelyn Baumgartner, Robert Chan, Vineet Mishra, Jeffrey D. Blume, Joseph A. Smith, Daniel A. Barocas, Smaller Prostate Size Predicts High Grade Prostate Cancer at Final Pathology, The Journal of Urology, 2010, 184, 3, 930

    CrossRef

  41. 41
    Shahrokh F. Shariat, Yair Lotan, Andrew Vickers, Pierre I. Karakiewicz, Bernd J. Schmitz-Dräger, Peter J. Goebell, Nuria Malats, Statistical consideration for clinical biomarker research in bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2010, 28, 4, 389

    CrossRef

  42. 42
    Peter C. Albertsen, Treatment of localized prostate cancer: when is active surveillance appropriate?, Nature Reviews Clinical Oncology, 2010, 7, 7, 394

    CrossRef

  43. 43
    Andrew J. Vickers, Paul Fearn, Peter T. Scardino, Mike W. Kattan, Why Can't Nomograms Be More Like Netflix?, Urology, 2010, 75, 3, 511

    CrossRef

  44. 44
    Shahrokh F Shariat, Michael W Kattan, Andrew J Vickers, Pierre I Karakiewicz, Peter T Scardino, Critical review of prostate cancer predictive tools, Future Oncology, 2009, 5, 10, 1555

    CrossRef

  45. 45
    Zohar A. Dotan, Jacob Ramon, Nomograms as a Tool in Predicting Prostate Cancer Prognosis, European Urology Supplements, 2009, 8, 9, 721

    CrossRef

  46. 46
    D. M. Fanning, F. Yue, J. M. Fitzpatrick, R. W. G. Watson, Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation, Irish Journal of Medical Science, 2009, 179, 2, 187

    CrossRef

  47. 47
    D M Moreira, J C Presti, W J Aronson, M K Terris, C J Kane, C L Amling, L L Sun, J W Moul, S J Freedland, The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases, Prostate Cancer and Prostatic Diseases, 2009, 13, 1, 87

    CrossRef

  48. 48
    Omar Hameed, What is the pathologist saying? Interpretation of the prostate pathology report, Current Prostate Reports, 2009, 7, 4, 141

    CrossRef

  49. 49
    Omar Hameed, What is the pathologist saying? Interpretation of the prostate pathology report, Current Urology Reports, 2009, 10, 3, 212

    CrossRef

  50. 50
    Matthew R. Cooperberg, Prostate cancer risk assessment, Cancer, 2008, 113, 11
    Direct Link:
View Full Article (HTML) Get PDF (447K)